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Sir2 mediates lifespan extension in lower eukaryotes but whether its mammalian homolog, sirtuin
1, silent mating type information regulation 2 homolog (SIRT1), is a longevity protein is controver-
sial. We stably introduced the SIRT1 gene into human vascular smooth muscle cells (SMCs) and
observed minimal extension of replicative lifespan. However, SIRT1 activity was found to be exqui-
sitely dependent on nicotinamide phosphoribosyltransferase (Nampt) activity. Moreover, overex-
pression of Nampt converted SIRT1-overexpressing SMCs to senescence-resistant cells together
with heightened SIRT1 activity, suppressed p21, and strikingly lengthened replicative lifespan. Thus,
SIRT1 can markedly postpone SMC senescence, but this requires overcoming an otherwise vulnera-
ble nicotinamide adenine dinucleotide salvage reaction in aging SMCs.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Michishita and coworkers found that replicative lifespan of humanSilent information regulator 2 (Sir2) is a protein deacetylase
that mediates the lifespan-extending actions of caloric restriction
in yeast [1]. In addition, extra copies or increased expression of
the Sir2 gene extend the lifespan of yeast, worms, and ﬂies [2–4].
The mammalian sirtuin with the highest sequence similarity to
Sir2 is sirtuin 1, silent mating type information regulation 2 homo-
log (SIRT1), a predominantly nuclear enzyme that is essential for
mammalian development [5]. SIRT1 can modify chromatin-associ-
ating proteins, transcription factors, and coregulators and, in so
doing, controls the expression of key regulators of cell defense,
metabolism, and survival [6]. Accordingly it might be expected
that, like Sir2 in lower organisms, SIRT1 is a mammalian longevity
protein. However, the capacity of SIRT1 to extend the replicative
lifespan of mammalian cells is uncertain and there have been con-
tradictory ﬁndings. In a seminal report, Langley et al. found that
SIRT1 overexpression in mouse embryo ﬁbroblasts inhibited pro-
myelocytic leukemia protein-induced senescence [7]. Likewise, re-
duced SIRT1 activity in MCF-7 cells and endothelial cells has been
reported to induce senescence-like growth arrest [8,9]. In contrast,chemical Societies. Published by E
eotide; Nampt, nicotinamide
ating type information regu-
hostatin A
ciences Centre, 339 Winder-
519 434 3278.
ng).ﬁbroblasts was unaffected by SIRT1 overexpression [10] and SIRT1
has been found to suppress telomerase activity in telomerase-
immortalized cells and hematopoietic stem cells [11]. Further con-
founding the question of a potential longevity role of SIRT1 is the
observation that SIRT1-deﬁcient mouse embryonic ﬁbroblasts have
extended, rather than shortened, replicative lifespan [12].
SIRT1 is a nicotinamide adenine dinucleotide (NAD+)-depen-
dent deacetylase and is thus linked to NAD+ metabolism. Nicotin-
amide phosphoribosyltransferase (Nampt, also known as PBEF
and visfatin) catalyzes a rate-limiting step in the NAD+ salvage
pathway that generates nicotinamide mononucleotide from nico-
tinamide [13]. Interestingly, increased Nampt expression has been
show to extend the lifespan of human smooth muscle cells (SMCs)
by increasing SIRT1-dependent p53 deacetylation [13]. However,
there are several pathways by which NAD+ can be made available
in mammalian cells and whether intracellular Nampt is absolutely
required for a given action of SIRT1 is uncertain. Moreover, if there
is such a requirement, it is worth recognizing that Nampt is not an
invariantly expressed enzyme. Instead, its abundance can be al-
tered by serum factors, cytokines, and circadian cycles [14–16].
Furthermore, and particularly important to the question of life-
span, Nampt activity declines as cells approach senescence [13].
We report here that overexpressing SIRT1 alone in human vas-
cular SMCs has minimal effect on replicative longevity but that
SIRT1 can strikingly extend lifespan if the aging-related decline
in the NAD+ salvage pathway can be overcome.lsevier B.V. All rights reserved.
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2.1. Cell culture
Experiments were performed using primary human SMCs and
the HITC6 clonal SMC line, both derived from segments of human
internal thoracic artery [17,18]. To quantify replication, cells were
seeded at a density of 4500 cells/cm2 and population doublings
were calculated using the formula: Log10[# cells har-
vested]  (Log10[# cells seeded]/Log10[2]).
2.2. Western blot analysis
Protein expression was assessed by immunoblot analysis of ly-
sates of conﬂuent SMCs, as described [19]. Primary antibodies in-
cluded mouse monoclonal antibodies against human p53 (DO-1,
Santa Cruz Biotechnology), human p21 (DCS-60, Santa Cruz Bio-
technology), and a-tubulin (B512, Sigma), and polyclonal antibod-0 10 20 30 40 50
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Fig. 1. SIRT1 minimally extends human SMC lifespan. Cumulative population
doublings of primary SMCs (A) and HITC6 SMCs (B) infected with retrovirus
containing vector (pQCXIP) or vector with cDNA encoding human SIRT1. Graphs
depict the averaged results from three longevity assessments and curves were ﬁt
using non-linear regression. (C) Western blots showing decreasing SIRT1 abun-
dance and increasing p53 and p21 expression in HITC6 SMCs serially subcultured to
senescence (S = subculture).ies raised against human SIRT1 (ab13749, Abcam) and human
Nampt (BL2122, Bethyl Laboratories). Secondary antibodies used
were horseradish peroxidase-conjugated anti-mouse or anti-rabbit
IgG Fab (Amersham Biosciences).
2.3. Overexpression of SIRT1 and Nampt in human SMCs
Stable overexpression of SIRT1 and Nampt in SMCs was carried
out using retrovirus-mediated gene delivery, as previously de-
scribed [19,20]. Retrovirus containing pQCXIP-Nampt-IRES-PURO
or pQCXIP-IRES-PURO (Clontech Laboratories) was generated by
calcium phosphate-mediated transfection of the Phoenix ampho-
tropic retrovirus packaging cell line (ATCC). Stable transductants
were selected with 3 lg/ml puromycin. SIRT1 was similarly trans-
duced using the pQCXIN retroviral expression vector and selected
with 400 lg/ml G418.
2.4. Senescence-associated beta-galactosidase activity
Senescence-associated b-galactosidase (SA-b-gal) activity was
determined in SMCs ﬁxed with 2% formaldehyde/0.2% glutaralde-
hyde for 3 min and by staining for b-galactosidase activity at pH
6.0, as described [21]. SMCs were counterstained with 2.5 lg/ml
Hoechst33258 and the proportion of SA-b-gal activity-positive
cells was quantiﬁed using light and ﬂuorescence microscopy.
2.5. Assessment of SIRT1 and Nampt activity
SIRT1 deacetylase activity was quantiﬁed in live cells as re-
ported [22] using 25 lM Fluor-de-Lys-SIRT1 ﬂuorogenic substrate
(Biomol) and quantifying reaction product in the media by spectro-
ﬂuorometry and normalizing to cell protein content. Nampt activ-
ity was determined in SMC lysates in 10 mM NaH2PO4/Na2HPO4,
pH 8.8, by quantifying the conversion of [carbonyl-14C]nicotin-
amide to acetone-precipitable nicotinamide mononucleotide, as
described [23].
2.6. Quantitative real-time RT-PCR
Transcript abundance was quantiﬁed by real-time RT-PCR. A
TaqMan-based primer/probe set (Applied Biosystems) was used
to detect human p21 (Hs00355782_m1) and a primer/probe set
for p16 was customized using the exon 1–2 boundary sequence.
Values were normalized to the endogenous reference GAPDH
(Hs00266705_g1).Vehicle FK866
0
500
1000
1500
*
SIRT1
α-tubulin
SI
RT
1
D
ea
ce
ty
la
se
Ac
tiv
ity
(A
FU
)
Ve
hic
le
8
FK
66
Fig. 2. SIRT1 deacetylase activity in SMCs is dependent on Nampt. SIRT1 activity in
HITC6 SMCs incubated with the Nampt antagonist FK866 (10 nM) or vehicle for
48 h was assessed based on NAD+-dependent deacetylation of an acetylated peptide
substrate in the presence of 1 lM trichostatin A. SIRT1 protein expression was
unaffected (inset) (*P < 0.005 vs. vehicle).
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3.1. Introducing SIRT1 into human SMCs trivially extends replicative
lifespan
To determine if the replicative lifespan of human vascular SMCs
was impacted by enhanced expression of SIRT1, we infected prolif-
erating human SMCs with retrovirus containing SIRT1 cDNA. Pop-0
2000
4000
6000
8000
10000
12000
14000
*
*
†
Nampt
+Nampt
Vector SIRT1 SIRT1
C
A
B
Vector SIRT1
Nampt SIRT1+Nampt
6.1 CPD 7.0 CPD
8.1 CPD 8.7 CPD
0 10 20 30 40
0
5
10
15
20
Vector
SIRT1
Nampt
SIRT1+Nampt
Cu
m
ul
at
ive
Po
pu
la
tio
n
D
ou
bl
in
gs
SI
RT
1
D
ea
ce
ty
la
se
Ac
tiv
ity
(A
FU
)
Fig. 3. Marked extension of human SMC lifespan by SIRT1 and Nampt. (A) Population dou
encoding SIRT1, Nampt, or both SIRT1 and Nampt. The pronounced increase in replica
senescence (B), determined after 35 days by staining for SA-b-gal activity at pH 6.0 (*P <
SIRT1 activity by Nampt (*P < 0.05 vs. vector, P < 0.001 vs. vector, SIRT1, and Nampt). (D)
quantitative real-time RT-PCR (*P < 0.05 vs. vector, SIRT1, and Nampt).ulation doublings of stable transductants were tracked until
proliferation ceased, a transition concurrent with accumulation
of ﬂattened and enlarged SMCs indicative of senescence. In pri-
mary cultures of adult SMCs, which are generally short-lived, there
was a modest (1.30 ± 0.93-fold, P < 0.01) increase in cumulative
population doublings in SIRT1-overexpressing cells (SIRT1–SMCs)
compared to vector-infected SMCs (Fig. 1A). In a clonal line of
non-immortal but longer-lived human SMCs [14,17,18], popula-50 60 70 80 90 100
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bling of HITC6 SMCs transduced with retrovirus containing control vectors, or cDNA
tive lifespan in SIRT1–Nampt SMCs corresponds to a substantial decrease in SMC
0.05 vs. vector, P < 0.05 vs. SIRT1 and Nampt). (C) Graph showing ampliﬁcation of
Graphs depicting abundance of p21 and p16INK4A mRNA in human SMCs, assessed by
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fold, P < 0.05) (Fig 1B). To determine if the reason for the minimal
effect on replicative lifespan was simply because endogenous
SIRT1 was already abundant, we serially tracked SIRT1 expression
in replicating, non-transduced SMCs. In fact, over six subcultures
SIRT1 content fell by 44 ± 13%, with a reciprocal rise in p53 and
p21, two pro-senescence proteins whose expression is repressed
by SIRT1-mediated deacetylation (Fig. 1C) [24]. Thus in aging SMCs
with otherwise declining SIRT1 content, introducing the SIRT1
gene had little effect on replicative longevity.
3.2. SIRT1 activity in SMCs depends on Nampt
The negligible effect of overexpressing SIRT1 on SMC longevity
could indicate either that SIRT1 is not a longevity protein for SMCs
or that the metabolic conditions for its activity were suboptimal.
Thus, we next determined if SIRT1 activity was dependent on
Nampt, an enzyme that increases NAD+ and clears nicotinamide,
using the speciﬁc Nampt antagonist, FK866 [25]. FK866 reduced
Nampt activity to 0.11 ± 0.05 of basal level (P < 0.001). This had
no effect on SIRT1 expression. However, SIRT1 activity fell to 28%
of baseline (Fig. 2). Thus, endogenous SIRT1 activity in SMCs is
highly dependent on Nampt activity.
3.3. Pronounced extension of human SMC longevity by paired
overexpression of Nampt and SIRT1
Given this, we next determined whether the only modest lon-
gevity effect of overexpressed SIRT1 would still be the case if
Nampt was also overexpressed. As shown in Fig. 3A, the effect of
combined overexpression was striking – replicative lifespan of
Nampt/SIRT1-SMCs was double that of control SMCs (1.97 ± 0.24-
fold increase) and 66% greater (1.66 ± 0.20-fold) that of SMCs over-
expressing SIRT1 alone (P < 0.001). To verify that the altered life-
span was related to senescence inhibition, cells were stained for
SA-b-gal activity. This revealed that the proportion of senescent
cells in cultures double-overexpressing SIRT1 and Nampt was sig-
niﬁcantly lower than that for either SIRT1–SMCs or Nampt–SMCs
(P < 0.05) (Fig. 3B). In addition, whereas SIRT1–SMCs had a 2.8-fold
increase in SIRT1 activity over baseline, double transductants had a
7.0-fold increase SIRT1 activity (Fig. 3C). When non-transduced
SMCs were supplemented with 50 lM nicotinamide mononucleo-
tide, a product of Nampt action and immediate precursor to NAD,
SIRT1 activity increased by 2.1-fold, supporting NAD+ content as
a limiting factor for SIRT1 activity in SMCs. We also found that
Nampt-SIRT1 SMCs expressed signiﬁcantly less p21, a downstream
effector of SIRT1 deacetylase activity (Fig 3D, P < 0.05). Interest-
ingly, expression of p16INK4A was not affected by Nampt/SIRT1
overexpression, suggesting that a Nampt-SIRT1 axis does not regu-
late expression of this particular longevity regulator.
4. Discussion
The ﬁndings reported here establish that increasing expression
of SIRT1 in aging SMCs has little effect on SMC lifespan, despite an
otherwise aging-related decline in SIRT1 expression. However, rep-
licative lifespan of SMCs can be extended markedly by SIRT1 if
Nampt, the rate-limiting enzyme for NAD+ salvage, is also overex-
pressed. This striking synergy is related to the dependence of SIRT1
on Nampt for its deacetylase activity. Therefore, SIRT1 can be con-
sidered a lifespan regulator for SMCs but this action may ulti-
mately depend on the metabolic milieu in which SIRT1 operates.
NAD+ is essential for SIRT1 activity because it supplies the ADP
ribose moiety necessary to accept the acetyl group from the SIRT1-
targeted protein [26]. Whether NAD+-generating enzymes besidesNampt are equally important to SIRT1 activity, particularly when
SIRT1 is overexpressed, is not known. However, the linkage be-
tween Nampt and SIRT1 may be particularly important given that
Nampt both generates NAD+ and clears nicotinamide, the latter an
inhibitor of SIRT1 that is hydrolytically released from NAD+ as part
of the deacetylation reaction. Recent evidence has also shown that
the downstream consequences of different NAD+ biosynthetic en-
zymes can differ, even for enzymes in the same linear pathway, a
ﬁnding that could reﬂect differential localization or microdomains
[27]. Regardless, the ﬁndings that SIRT1 in SMCs requires Nampt,
and that Nampt can be a vulnerable enzyme that declines as SMCs
age [13], highlight the importance of considering Nampt activity
when studying SIRT1-mediated responses.
Our ﬁndings may explain the apparently discrepant published
results regarding SIRT1 and mammalian cell longevity with reports
indicating that SIRT1 inhibits senescence [7–9], promotes senes-
cence [11,12], or has no effect on senescence at all [10]. We pro-
pose that these variable ﬁndings may, at least in part, reﬂect the
vulnerability of Nampt and differences in the efﬁciency with which
nicotinamide is converted to NAD+. Augmenting SIRT1 expression
in cells with limited capacity to salvage NAD+ from nicotinamide
may have little, if any, effect on SIRT1-mediated processes. In con-
trast, there may be a strong effect if endogenous Nampt activity re-
mains robust.
In summary, these data establish that the actions of SIRT1 must
be considered in the context of the prevailing, and aging-sensitive,
metabolic pathways that regulate the biosynthesis of NAD+. This
may be particularly important as therapies designed to exoge-
nously activate SIRT1 are pursued. Senescent SMCs can destabilize
the artery wall because they are proinﬂammatory and lose their
capacity to proliferate [28]. Strategies that enhance both SIRT1
content and Nampt activity may hold promise for stabilizing dis-
eased arteries and other aging tissues.
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